SHORT-COURSE CHEMOTHERAPY IN PULMONARY TUBERCULOSIS - CONTROLLED TRIAL BY BRITISH THORACIC AND TUBERCULOSIS ASSOCIATION

被引：0
作者：
不详
机构：
来源：
LANCET | 1975年 / 1卷 / 7899期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：119 / 124
页数：6
相关论文
共 19 条
[1]  
[Anonymous], 1960, Bull World Health Organ, V23, P535
[2]  
[Anonymous], 1973, Lancet, V1, P1331
[3]  
[Anonymous], 1974, Lancet, V2, P1100
[4]  
[Anonymous], 1974, Lancet, V2, P237
[5]  
[Anonymous], 1972, LANCET, Vi, P1079
[6]   SERUM ENZYME CHANGES IN PATIENTS RECEIVING ANTITUBERCULOSIS THERAPY WITH RIFAMPICIN OR PARA-AMINOSALICYLIC ACID, PLUS ISONIAZID AND STREPTOMYCIN [J].
BARON, DN ;
BELL, JL .
TUBERCLE, 1974, 55 (02) :115-120
[7]  
BROUET G, 1974, 17 C NAT TUB MAL RES, P27
[8]  
CROFTON J, 1960, BRIT MED J, V2, P678
[9]   EFFECT OF RIFAMPICIN AND ISONIAZID ON LIVER FUNCTION [J].
LAL, S ;
BURLEY, DM ;
SINGHAL, SN ;
CROSSLEY, G .
BRITISH MEDICAL JOURNAL, 1972, 1 (5793) :148-&
[10]  
Lal S, 1969, Tubercle, V50, P269, DOI 10.1016/0041-3879(69)90051-8
12